Which I guess comes back to the member's first question, which is in relation to the Māori advisory board. I'm not aware of changes to the functions and powers of that board. What I do know is that with Te Aka Whai Ora now being established, it's my expectation that Pharmac will establish a very close relationship with Te Aka Whai Ora, because we know in terms of its equity performance, Māori have done particularly badly in that respect. We look at the cancer treatments that they have given priority to—typically cancer treatments that are not the ones that Māori are more statistically susceptible to.